Lymphoma Working Party (LWP)
Study type:
Study number:
2009-N-02
Type of treatment:
Diseases:
Other myeloid or lymphoid malignancies
Short title:
NIS BPDCN
Primary objective:
Key inclusion criteria:
Patients submitted for allo or auto SCT with diagnosis of BPDC as proven by state-of-the-art histological, cytological, immunophenotypical, genetical and/or molecular diagnostic work-up.
Country:
Principal investigator:
Sascha Dietrich, Peter Dreger
EBMT Study coordinator:
Hervé Finel